- 全部删除
您的购物车当前为空
GK563是一种针对Ca2+-independent phospholipase A2(GVIA iPLA2)的选择性抑制剂,具有1 nM的IC50值。相比于GIVA cPLA2,GK563对GVIA iPLA2的抑制活性高出22000倍。它能减少促炎细胞因子诱导的β-cell凋亡,从而增加了其在对抗自身免疫性疾病(例如1型糖尿病)中的潜在应用价值。

GK563是一种针对Ca2+-independent phospholipase A2(GVIA iPLA2)的选择性抑制剂,具有1 nM的IC50值。相比于GIVA cPLA2,GK563对GVIA iPLA2的抑制活性高出22000倍。它能减少促炎细胞因子诱导的β-cell凋亡,从而增加了其在对抗自身免疫性疾病(例如1型糖尿病)中的潜在应用价值。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,330 | 35日内发货 | |
| 5 mg | ¥ 9,870 | 35日内发货 | |
| 10 mg | ¥ 18,200 | 35日内发货 |
GK563 相关产品
| 产品描述 | GK563, a selective Ca 2+-independent phospholipase A2 (GVIA iPLA2) inhibitor, exhibits a potent IC50 value of 1 nM and demonstrates 22,000-fold greater activity against GVIA iPLA2 compared to GIVA cPLA2. Its efficacy in reducing β-cell apoptosis triggered by proinflammatory cytokines suggests potential therapeutic benefits in combating autoimmune disorders, including type 1 diabetes. |
| 分子量 | 246.34 |
| 分子式 | C16H22O2 |
| CAS No. | 2351820-19-2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容